Achalasia other diagnostic studies

Revision as of 16:51, 27 August 2012 by Charmaine Patel (talk | contribs) (Created page with "__NOTOC__ {{Achalasia}} {{CMG}} ==Overview== ==Other Diagnostic Studies== *Manometry, the key test for establishing the diagnosis. A probe measures the pressure waves i...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Achalasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Achalasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Achalasia other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Achalasia other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Achalasia other diagnostic studies

CDC on Achalasia other diagnostic studies

Achalasia other diagnostic studies in the news

Blogs on Achalasia other diagnostic studies

Directions to Hospitals Treating Achalasia

Risk calculators and risk factors for Achalasia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Other Diagnostic Studies

  • Manometry, the key test for establishing the diagnosis. A probe measures the pressure waves in different parts of the esophagus and stomach during the act of swallowing. A thin tube is inserted through the nose, and the patient is instructed to swallow several times.
    • Elevated resting LES pressure, usually > 45 mmHg.
    • Incomplete relaxation of the LES.
    • Aperistalsis – contractions may be absent, diffuse and not coordinated, and / or ‘vigorous’ (> 60 mmHg).
  • Most patients should get and EGD – primarily in order to rule out malignancy (esophageal and gastric).
    • Findings include a dilated esophagus with residual pill / food fragments, normal mucosa and occasionally candidiasis (due to the prolonged stasis).
    • Factors associated with an increased risk of malignancy include symptoms less than 6 months, presentation after 60 years old, excessive weight loss and difficult passage of the endoscope through the gastroesophageal junction.
    • As malignancies can be intramural and not visible with the scope, repeat EGDs with biopsy are recommended when there is a ‘high’ suspicion of malignancy.
  • Cholecystokinin (CCK) stimulation test: CCK causes mild contraction of the LES and a more pronounced release of inhibitory neurotransmitters in the wall of the esophagus. In normal people, LES tone will decrease due to the predominant effect of the inhibitory neurotransmitters. In patients with achalasia, however, the stimulatory effect on the LES is unopposed, and LES pressure increases.

References